Microglia are phagocytic cells that are chemoattracted by brain tumors and can represent up to 70% of the tumor cell population. To get insight into gene therapy against glioma, we decided to take advantage of those microglia properties and to use those cells as vehicles to transport simultaneously a suicide gene (under the control of a heat-sensitive promoter) and contrast agents to localize them by magnetic resonance imaging before applying any therapeutic treatment. Thymidine kinase (TK) expression and its functionality after gancyclovir administration were investigated. After the heat shock (441C and 20 min), TK was expressed in 50% of the cells. However, after gancyclovir treatment, 90% of the cells died by apoptosis, showing an important bystander effect. Then, the cells were incubated with new lanthanide contrast agents to check both their potential toxicity and their MR properties. Results indicate that the nanoparticles did not induce any cell toxicity and yield a hypersignal on MR images at 4.7 T. These in vitro experiments indicate that microglia are good candidates as vectors in gene therapy against brain tumors. Finally, microglia containing gadolinium-grafted nanoparticles were injected in the close vicinity of C6 tumor, in a mouse. The hyperintensive signal obtained on in vivo images as well as its retention time show the potential of the novel contrast agents for cellular imaging.
Introduction
Malignant gliomas are the most common primary brain tumors. They are highly aggressive tumors and are characterized by a recurrence rate of nearly 100%, even with treatments like surgery, radiation or chemotherapy. Despite significant advances in neuroimaging and neurosurgical techniques, the median survival time of patients with glioblastomas has barely improved over the past 30 years and remains poor: between 12 and 18 months after the prognosis.
Microglial cells come from monocytes and belong to the immune system. They are macrophages specific to the central nervous system and represent 5-20% of the glial population. 1 They are very sensitive to the homeostatic modifications that arise when inflammatory reactions, trauma or nervous cell degeneration occur. 2 Indeed, microglia change their behavior when a glioma develops as they release granulocyte macrophage-colony stimulating factor (GM-CSF), which chemoattracts microglia to the tumor site and leads to their proliferation. 3 Consequently, in a cerebral tumor, macrophages and microglia can represent up to 70% of the cellular population depending on the brain tumor type. 4, 5 In the view of these properties, microglia could be used as a therapeutic vector to transport a gene of interest to the glioma. Some studies have already tested this hypothesis. Indeed, microglia were transfected with the LacZ gene:
6 48 h after intraarterial injection, they were mainly detected in the rat brain, confirming that microglia could be used to transport a transgene specifically to glioma.
In gene therapy, several genes have been employed such as antiangiogenic genes (siRNA anti-vascular endothelial growth factor, 7 ) and suicide genes (cytosine desaminase, 8 thymidine kinase (TK), 9 y). The presence of the herpes simplex virus TK leads to cell death after the administration of one of its substrates, gancyclovir (GCV). Indeed, tri-phosphorylated GCV induces a DNA replication stop. 10 Moreover, the TK/GCV system is suitable because it induces a bystander effect: [11] [12] [13] first, monophosphorylated GCV can pass through intercellular gap junctions and then trigger the death of cells that have not been transduced; second, apoptotic bodies released by dead cells can be taken up by adjacent viable cells and induce an amplification of this phenomenon. Thus, a small quantity of enzyme and a low level of transduction are sufficient to lead to tumoral regression. 14 Furthermore, the TK/GCV system has a clear advantage, in that it provides a pharmacological control as intracellular signaling occurs only if GCV is administered.
A major problem lies in the fact that the transgene expression must be strictly limited to the tissue of interest. Numerous strategies have been developed to compensate this lack of specific targeting. One of them, transcriptional control, has to drive the transgene expression with both a temporal and spatial control. Some teams have used pharmacological activation like the tetracycline system switch, 15 but the lack of specific spatial induction involves in return a particularly specific targeting of the tissue, which is not yet completely mastered. Therefore, another strategy consists in the use of promoters sensitive to physical inducers. Some physical activations have been used such as radiation 16 or hyperthermia. The disadvantage of the radioactivation is its inability to deposit energy strictly at the level of the tissue concerned. Moreover, the radiotherapy generates secondary effects on healthy tissues that are on the ray beam. However, the temporal and spatial control of suicide gene expression can be realized by a local heat induction with heat-sensitive promoter. For in vivo applications, hyperthermia applied with focalized ultrasounds (FUS) appears more suitable because the temperature elevation is non-invasive, non-toxic for neighboring tissues and the size of the focal point can be restricted to several millimeters. 17, 18 However, FUS cannot be used for glioma therapy because they are deflected by the skull. Another method to get a local heat is the application of radio frequency, a mean that is technically compatible with magnetic resonance imaging (MRI).
MRI is an often-used technique because images are obtained non-invasively and at a spatial resolution potentially reaching the cellular scale. 19 Many studies have demonstrated the interest of using iron-based contrast agents like superparamagnetic particles (US-PIO). 20 Although they display many advantages, like being detected at low concentrations, these nanoparticles induce a hyposignal, which can be misinterpreted as an artifact. Moreover, they can be difficult to detect if they are located in a tissue characterized by a low signalto-noise ratio (for example, liver). Furthermore, the diffuse signal prevents the characterization of their precise localization owing to sensitivity to magnetic effects. New families of contrast agents based on lanthanide (like gadolinium chelates-grafted nanoparticles 21 ) or on liposomes are under study. 22 Indeed, even if the lanthanide detection threshold is higher than the one for USPIO, these new nano-objects can link many gadolinium molecules together in a close vicinity and thus can increase the MRI signal-to-noise ratio. Furthermore, in the presence of gadolinium, the area of interest appears as a hypersignal on T 1 -weigted images. This makes sure that the intense signal is only linked to the presence of the lanthanide and also allows to monitor the appearance or extinction of the signal as function of time. In addition, gadolinium-based contrast agents give a precise spatial localization and resolution because the MR sequences are less sensitive to susceptibility effects, as demonstrated in common MR angiography. 23 Consequently, gadolinium appears as a good candidate to visualize precisely a cell population in vivo. 24 Using the properties of phagocytosis, microglia could become visible vectors in vivo. Indeed, contrast agents can be taken up by microglia in vacuoles, thus allowing the microglia location in the body. 25 This property is not limited to this population, as stem cell trafficking in vivo has also been characterized by MRI. 26 Furthermore, the localization of the nanoparticles inside the microglia will increase the half-life of the contrast agent in animals which will become much higher than that of gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) injected in the blood stream, whose clearance is faster because of its vascular and cell interstitial location. The combination of nanoparticle internalization due to the macrophagic ability of the microglial cells and their chemoattraction by tumoral cells are two properties that could be used in specific brain tumor imaging.
The purpose of this study is to demonstrate the potentialities of microglia as a vehicle for gene therapy and as a visualizable vector by MR at the same time. For this purpose, microglial cells were transduced to express the TK gene coupled to the green fluorescent protein (GFP) gene after a heat shock. Indeed, the fusion gene was placed under the HSP70 promoter. This promoter lacks regulatory regions sensitive to stress other than heat, making it suitable for targeted therapy, and provides a local and temporal control of transgene expression. 27 The first aim of this study was to characterize in vitro TK gene expression by heat induction as well as its functionality. Thereafter, MR images were realized in microglia after internalization of Gd-DTPA-grafted nanoparticles, both in vitro and in vivo.
Materials and methods

Cell culture
The fusion gene TK-GFP under the HSP70 promoter has been constructed as described by Guilhon et al. 28 Briefly, the TK-GFP gene was extracted from the plasmid ETLGB 29 and inserted in the pcDNA3-HS. 30 The construct with the TK-GFP gene under the control of the HSP70 promoter was isolated after bglII and SalI digestions. The insertion in the lentivirus PCS ferroch 31, 32 was realized after BamHI and XhoI digestions. The transduction was performed with the microglial cell line grown in Dulbecco's modified Eagle's medium (DMEM)-fetal calf serum (FCS) medium: 5 Â 10 5 cells in suspension were incubated with 2 ml of viral supernatant collected at 24 h added of 4 mg/ml polybrenne (Gibco BRL, Carlsbad, CA, USA) corresponding to a MOI 15. The medium was changed 8 h later. Heat-sensitive microglia were then tested and produced following culture conditions similar to the ones of the microglia cell line.
An enriched population was created by cell sorting so that 50% of PHT cells expressed the TK-GFP transgene after the heat shock. Microglia were plated on 10-cmdiameter Falcon dishes and grown in an minimum essential medium (Eurobio, Les Ulis, France) supplemented with FCS (10%), D-glucose (4 g/l; Sigma, St Quentin, France), L-glutamine (584 mg/l; Sigma), sodium bicarbonate (2 g/l; Labosi, Elancourt, France), penicillin (10 000 mg/ml), streptomycin (10 000 mg/ml) and amphotericin B (25 mg/ml), in a water-saturated incubator at 371C in an atmosphere of 5% CO 2 /95% air.
Heat shock PHT microglia were collected at a cell density of 1.7 Â 10 6 cells/ml in 3 ml of RPMI (Gibco) 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES). The heat shock was administered at 441C for 20 min in a water bath. Then, cells were plated on 10-cm Falcon dishes in DMEM medium-10% FCS. Recovery times were adjusted according to the performed studies. GCV was applied 24 h after the heat shock.
Cell viability
To study the drug effect on microglial viability, cells were plated on 24-well plates and incubated with increasing concentrations of GCV (0, 0.011, 0.018, 0.025, 0.036, 0.054, 0.072, 0.108, 0.4, 1.1 and 3.6 mM) for 4, 24, 48 or 72 h. Incubations started 24 h after the heat shock. Cells were collected by trypsinization and counted on a Malassez slide after a trypan blue staining.
Flow cytometry
Flow cytometric studies were carried out on a fluorescent assay cell sorter (FACS Calibur; Becton-Dickinson, Le Pont-De-Claise, France) working with an argon laser (emission wavelength at 488 nm). For each analysis, at least 5000 events were counted. The transgene expression in PHT cells was determined using GFP fluorescence (l exc ¼ 480 nm and l em ¼ 510-520 nm) at different recovery times (19, 24, 43, 48, 67, 72, 91 and 96 h) after the heat shock. Cells expressing GFP were noted as GFP þ . The evolution of the redox potential was evaluated using a mitochondrial potential probe, 3,3 0 -dihexyloxacarbocyanine iodide (DiOC6(3), l exc ¼ 488 and l em ¼ 522 nm; Molecular Probe -Interchim, Montlucon, France). DiOC6(3) accumulates preferentially in mitochondria displaying a high intermembrane potential. Microglia were incubated with DiOC6(3) (100 nM) for 10 min at 371C. Cells were then collected by trypsinization and spun down (180 g for 10 min). The pellet was homogenized in 1 ml RPMI, 10 mM HEPES, stored at 41C and the cellular suspension was analyzed after being diluted (1/2) in phosphate-buffered saline (PBS). The DiOC6(3) fluorescence was analyzed at 4, 24, 48 and 72 h after incubation with GCV (0, 0.018, 0.036, 0.36, 1.1 and 2 mM). Apoptosis state was tested using the fluorescent inhibitor SR-DEVD-FMK (l exc ¼ 550 and l em ¼ 600 nm; Molecular Probe -Interchim), which binds to the activated caspases 3 and 7. Microglia were collected, spun down (180 g for 10 min) and re-suspended in 300 ml of RPMI. Then they were incubated with the inhibitor solution according to the manufacturer's instructions. The inhibitor fluorescence was analyzed 24, 48 and 72 h after incubation with GCV (0, 0.036, 1.1 and 2 mM).
Nanoparticle internalization
Microglial cells were activated for 24 h with C6 glioma cell-sonicated extracts in FCS-deprived medium. Then, they were incubated for 4 h with 170 nM silica beads coupled with tetramethyl rhodamine isothiocyanate (TRITC) or grafted with gadolinium. After 3 washes with PBS, cells were collected and either the fluorescence was analyzed by flow cytometry (l exc ¼ 480 nm , l em ¼ 590 nm) or the MRI signal was observed at 4.7 T. For MRI visualization, PHT cells were collected and trapped in an agarose gel (1%).
Labeled PHT cells in vivo C6 tumor cells suspension (10 6 cells in 100 ml of DMEM medium) was injected sub-cutaneously into the back of female mice (n ¼ 3). Tumor sizes were followed during time until reaching palpable tumors. Then, 20 Â 10 6 PHT microglia that have been just before incubated with silica nanoparticles grafted to gadolinium during 4 h, were injected in the close vicinity of the tumor and the MR signal was analyzed at 4.7 T at different time points. 
Nanoparticle toxicity tests
Microglial cells grown in 35-mm dishes and activated for 24 h were incubated with 170 nM of silica beads coupled to gadolinium for 4 h. After two washes with PBS, cells were collected and put in 10-cm dishes for 24, 48 or 72 h. At each time point, microglial cells were incubated with either DiOC6(3) (100 nM) for 10 min or with nonyl acridine orange (NAO, 5 mM) for 30 min at 37 1C. Then, the cells were collected and spun down (180 g for 10 min). The cell pellets were re-suspended in 1 ml of PBS for flow cytometric analysis.
Furthermore, after being collected and spun down (180 g for 10 min), the cell pellets were homogenized in 1 ml of PBS and incubated either with propidium iodide (PI, 3 mg/ml) for 10 min, or with caspases 3 and 7 inhibitor (SR-DEVD-FMK; Molecular Probe -Interchim) or with MTT formazan (1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan, 0.5 mg/ml; Sigma-Aldrich, St Quentin, France) for 45 min at 371C. After centrifugation (180 g for 10 min), the pellets were re-suspended in 1 ml of PBS and analyzed by flow cytometry. The MTT signal was measured on a spectrophotometer at 570 nm, compared to control cells after DMSO (dimethyl sulfoxide) solubilization.
Results
TK-GFP expression after the heat shock
Wild-type human microglial cell line (CHME-5) transduced with a plasmid containing the thymidine kinase-GFP (TK-GFP) fusion gene placed under the minimal human HSP70 promoter 28 is termed 'PHT cells'. After the heat shock (441C for 20 min), the transduced microglia (PHT cells) expressed the fusion protein TK-GFP (Figure 1a and b). GFP fluorescence analyzed 24 h after the heat shock showed a heterogeneous cell population. However, few cells were unable to express the transgene. The fluorescence was localized in the cytoplasm. Cells displayed a nuclear fluorescence according to the sequence targeting of the TK gene.
Flow cytometry was used to evaluate TK-GFP gene expression at different recovery times after the heat shock (from 0 to 96 h). In normal culture conditions, more than 95% of the population did not express the TK-GFP ( Activity of the TK-GFP protein after the heat shock The TK activity was determined as a function of cell viability after the heat shock and during prodrug GCV treatment at different concentrations. The ability of the cells to release trypan blue, and the assess of the mitochondrial membrane potential evolution using the fluorescent probe DiOC6(3) were analyzed to characterize the cell viability. The induction of the apoptosis pathway due to the TK/GCV-induced DNA fragmentation was observed using a fluorescent inhibitor of the activated 3 and 7 caspases. The proportion of living cells decreased according to a dose/response profile ( Figure 3) , with a half effect (IC 50 ) obtained at 0.1 and 0.05 mM of GCV after 48 and 72 h of incubation, respectively. At 3.6 mM of GCV, cell death reached 80 and 90% of the microglial population after 48 and 72 h of incubation, respectively. It is important to note that PHT cells that have not been subjected to the heat shock appear not sensitive to the prodrug for GCV concentrations that were lower than 7 times the IC 50 value. However, at GCV concentrations 30 times higher than the IC 50 , 45% of the cell population was affected (data not shown). Furthermore, similar experiments demonstrated that the wild type microglia viability was not affected by the incubation with the GCV (data not shown).
Apoptosis and necrosis are two major admitted pathways at the origin of the cell death. To study the thymidine kinase functionality, the cell death described previously had been analyzed to determine if the apoptosis process occurred, and if this phenomenon involved the mitochondrial or the nuclear pathway. To appreciate the modifications of the mitochondrial properties during the cell death, the cellular accumulation of the DiOC6(3) probe that is affected by mitochondrial potential variations, had been analyzed by fluorescence. 33 The emission fluorescence wavelengths for GFP and DiOC6(3) are similar (520 nm). Consequently, the contribution of GFP fluorescence to the one of DiOC6(3) has been determined. It accounted for 4% of the highest DiOC6(3) fluorescence level, whereas it represented 30% of the lowest DiOC6(3) intensity. To get round this technical difficulty in the flow cytometric analyzes, the ratio of fluorescence intensity in the search for the potential has not been considered, but rather the ratio of cell numbers present in each population. In this way, it was possible to observe the shift between the two populations displaying either a high level of fluorescence or a low level (Figure 4a ). The first one (Figure 4a , M1 area), which constituted 92% of the entire wild-type population, strongly accumulated the probe and represented a normal cell state. On the other hand, a 20 times decrease in probe accumulation was observed in the second population, which represented 8% of the wild-type microglia (Figure 4a, M2 area) .
The ratio of cells displaying a low fluorescence level to those showing a high level, that is 'DiOC6(3) low/ DiOC6(3) high ratio' (Figure 4b ), characterized the fluorescence shift during incubation with increasing GCV concentrations applied 24 h after the heat shock. Indeed, the cell population with high fluorescence (Figure 4a, M1) decreased, whereas the one with a low level (Figure 4a , M2) increased for higher GCV concentrations. When microglial cells were incubated with GCV concentrations lower than 0.36 mM, the balance between M1 and M2 was not significantly affected ( Figure 4b ). However, using 1.1 and 2 mM of GCV, the M1 population shifted drastically toward the M2 population after 72 h of Gene and contrast agents in microglia E Ribot et al GCV incubation. Indeed, the ratio at this time was 6 times higher than the one obtained when GCV concentrations were lower than 0.36 mM (ratio varying from 0.5 to 3). Furthermore, flow cytometric analyses of the apoptosis pathway via incubation with a fluorescent inhibitor of activated caspases 3 and 7, showed a similar cell distribution: one population detected with a low signal of fluorescence, representing a low level of activated caspases and indicating the normal living state of the cells; and another population with a high fluorescence mean, indicating that these cells had entered apoptosis. After the heat shock, these enzymes were activated in nearly 40% of the population and remained constant for different times of recovery without affecting their cell viability (data not shown). Therefore, the ratio between the number of activated-caspase cells due to the GCV treatment after the heat shock and the number of activated-caspase cells submitted only to the heat shock was calculated, to estimate the GCV effect on the cell viability. The percentage of activated-caspase cells did not change after 24 h of incubation whatever the GCV concentrations were ( Figure 5 ). At low GCV concentrations compared to the IC 50 , the caspase activation was not increased in microglia incubated during different times with the prodrug. However, the proportion of cells with activated caspases strongly increased when GCV concentrations were 1.1 or 2 mM, as soon as 48 h of treatment, with a four times increase in the percentage of fluorescent cells after 72 h of incubation.
Microglia imaging
Activated microglia displayed a macrophagic behavior. These cells can internalize nanoparticles, so they can be used as contrast agent vehicles. An important step was to determine the part of the signal due to the low proportion of the free beads still present after the medium was discarded versus the part assigned to internalized and cell surface-trapped beads. Thus, TRITC-grafted silica nanoparticles were incubated with microglia cells and analyzed both qualitatively by fluorescence microscopy and quantitatively by flow cytometry.
The microscopic fluorescence observation ( Figure 6 ) revealed an important accumulation of the beads inside the cells and also at the cytoplasmic membrane level without preclude if nanoparticles are still adsorbed at the cell surface or being inside invaginations of the cell membrane at different steps of uptake. At higher magnification ( Figure 6, insert) , the intracellular accumulation appeared localized in vesicles. The lack of fluorescence in intercellular spaces suggests that free particles should poorly contribute to the total fluorescence signal. Quantitative characterization of cellassociated beads (linked or internalized) was done by flow cytometry (Figure 7) . On the basis of particle size, there was no overlap between the nanoparticles and the cell populations (Figure 7a and d) . This allowed us to characterize two statistical areas: R1, containing 96% of the free nanoparticles ( Figure 7a and Table 1 ); and R2 containing 99% of the microglial cells (Figure 7d and Table 1 ). After incubation of the nanoparticles with the microglia cells, 94% of the events were located in R2 (Figure 7g ) and characterized by a 75 a.u. fluorescence mean (Figure 7i ), whereas in R1 (Figure 7g) , 6% of the events displayed a fluorescence mean of 63 a.u (Figure 7h) . To characterize the fluorescence signal attributable only to cell-associated nanoparticles located in R2 after the nanoparticle incubation with the cells, the contribution of the free nanoparticles still located in this R2 area had to be evaluated and subtracted from the total signal observed in it. When alone, free TRITC nanoparticles were mainly located in R1 (96%), whereas after incubation with microglia, only 6% of these particles were still located in R1 (Figure 7h and Table 1 ). Thus, the percentage of free nanoparticles in R1 had decreased 16 times after microglial incubation. This ratio could be applied to free TRITC nanoparticles located in R2 (representing 4% with a 147 a.u. fluorescence mean, Figure 7c and Table 1 ).
Indeed, preceding data demonstrate that microglia uptake was independent of the size of the particles between 20 and 100 mM. 34 This size range corresponds to the diameter of the silica nanoparticles that were incubated with microglia. Therefore, the decreased ratio of free nanoparticles observed in R1 after incubation with microglia cells can be applied to the free TRITC nanoparticles located in R2. After microglial uptake, there would be only 0.25%, (4%/16) of free TRITC nanoparticles located in R2. Consequently, the contribution of the free TRITC nanoparticles still located in R2 after microglial incubation could be estimated to be 0.4 a.u. (147 Â 0.25%, Table 1 ).
Furthermore, the intrinsic fluorescence due to the microglia cells in R2 (Figure 7f and Table 1) 3.3 a.u. and had to be subtracted from the R2 total signal. The percentage of cells located in R2 could be considered as 94% of the events obtained after the cell incubation minus 0.25% of the free TRITC nanoparticles, that is 93.75%. Thus, the intrinsic signal of the microglia cells contributed to less than 3.1 a.u. of the total signal obtained after nanoparticle incubation (3.3 Â 93.75%, Table 1 ).
Therefore, the fluorescence intensity due to microgliaassociated nanoparticles could be calculated as a value of 71.5 a.u. (75-0.4-3.1, Table 1 ), which represented about 95% of the total signal. To determine whether it was possible to obtain an MR image of the cell-associated nanoparticles, activated microglia were incubated with 170 nM of silica beads coupled with gadolinium. T 1 -weighted images revealed a 7.9 signal-to-noise ratio at 4.7 T before incubation with the nanoparticles. However, after incubation with the silica beads, a 27.5 signal-to-noise ratio was obtained. Thus, there was nearly a 3.5-fold increase in the signal when the nanoparticles were internalized and/or trapped at the cell surface (Figure 8 ). The relaxivity of the microglia containing these nanoparticles was T 1 ¼ 704 ms representing an important decrease compared to the T 1 value measured on control cells (T 1 ¼ 2482 ms). From these data, the amount of microglia-associated nanoparticles can be estimated. When plotted on the relaxivity curve obtained with increasing concentrations of silica beads grafted to gadolinium (r 1 ¼ 168 mM À1 s, data not shown), it was established that the concentration of nanoparticles associated with microglia was 5 mM, although bead concentration in the incubation medium was 0.17 mM.
Nanoparticle toxicity
The potential cytotoxicity of the cell-associated nanoparticles was determined after incubations with silica nanoparticles for 24, 48 or 72 h. Various tests were performed to characterize the cell viability (MTT and PI), the mitochondrial properties (NAO and DiOC6 (3)) and the eventual triggering of the apoptotic pathway (activation of caspases 3 and 7; Figure 9a ). Moreover, the leaky expression of the stress-inducible TK-GFP gene was also monitored after incubation of the microglial cells with the contrast agents (Figure 9b ). The mitochondrial cellular content (analyzed by NAO fluorescence) was not altered after incubation with nanoparticles. Furthermore, the mitochondrial potential level that drives DiOC6(3) accumulation was also not altered during the treatment. Moreover, the microglial dehydrogenase activities reflected by the MTT reduction in formazan salts did not show any decrease in viability during incubations with the gadolinium-grafted nanoparticles. In addition, the extracellular membrane integrity was not affected since PI was not cell permeant and did not bind to the DNA of the microglia cells after nanoparticle incubation. Furthermore, the increases in caspase 3 and 7 activities were not significantly detected in cells incubated with the nanoparticles. Finally, after incubation with the gadoliniumgrafted nanoparticles, the TK-GFP expression was monitored. The cytometric analyzes did not reveal any significant induction of the GFP by the contrast agent itself. In addition, after a heat shock, the transgene expression was not altered in microglia cells that had first internalized and trapped the nanoparticles.
In vivo visualization of the cell vehicles
After the in vitro MR detection of PHT cells incubated with silica nanoparticles grafted to gadolinium, similar experiments were realized in vivo on mice. Following incubation with the contrast agents, the PHT cells were injected in the vicinity of subcutaneous C6 tumor induced on the back of mice (Figure 10 ). The signal-to-noise ratio reached a value of 2, 24 h after the injection. This ratio decreased with time, being still significant (1.4) 1 week after the injection. Indeed, PHT cells were still present and detectable in the vicinity of the tumor 1 week after the injection in the mice. On the contrary, PHT microglia that Abbreviation: TRITC, tetramethyl rhodamine isothiocyanate. The '% of events' represents the statistical percentage of fluorescent events evaluated by the cytometer in areas R1 and R2. The fluorescent events are representative of either free fluorescent nanoparticles, fluorescent microglia or both, depending on the experiments. The 'fluorescence mean (fm)' represents the statistical average intensity of fluorescence in the two areas. '% Â fm' is the product of the number of events with its fluorescence mean, only in the R2 area. The '% of the total signal' represents the part of the total signal of the free and the cell-associated nanoparticles detected in R2. 'Control cells alone' values (represented in Figure 7d-f) , 'Free TRITC nanoparticles' values (represented in Figure 7a-c) and 'Cellassociated TRITC nanoparticles' values (represented in Figure 7g -i) were from three independent experiments. When microglia were analyzed as control, the fluorescence mean corresponds to the background. When the analyzes were performed after the incubations of the microglia cells with the fluorescent nanoparticles, the statistical events could be related to the still present free nanoparticles and to the microglia-associated nanoparticles. Figure 8 MR images of wild-type microglia before and after incubation with silica beads coupled with gadolinium. The PHT microglial cells (a) before and (b) after incubation with 170 nM of contrast agents were fixed and trapped in agarose gels as described in Materials and methods section. T 1 -weighted images were performed on these two samples. A hypersignal is observed when microglia cells had been incubated with the gadolinium-grafted nanoparticles. MR, magnetic resonance.
have not been in the presence of the contrast agents are not detectable (data not shown).
Discussion
The aim of this study was to determine whether microglia could be used both as therapeutic vectors for glioma therapy and MRI contrast agent tanker to be visualized by MRI. Wild-type microglia were transduced by lentiviral constructs to express the fusion protein TK-GFP in an inducible manner, as described by Guilhon et al 28 when studying C6 glioma sensitivity for thermotherapy induced by FUS. As a first step, the thermoinduction and efficiency of the expressed transgene were studied through the cell viability, mitochondrial potential and engagement of the apoptotic pathway. Furthermore, this strategy needs a targeting for the suicide gene. Thus, the correct localization of the PHT cells must be established. Therefore, contrast agents and MRI were used to visualize the transduced microglia after internalization of the nanoparticles. Indeed, MRI is the optimal technique to monitor and confirm, in a noninvasive manner, the migration and the correct glioma location of microglia cells that carry the suicide gene. The optimal expression of the TK-GFP gene was obtained with a heat shock at 441C for 20 min. This condition was similar to that obtained on C6 cells transfected with either GFP alone 27 or the TK-GFP gene under the control of the human HSP70 promoter. 18 These results strengthened the concept that HSP70 promoter activity was independent of cell species (human versus rat) and cell type (C6 glioma versus microglial cells).
The TK-GFP fusion protein was highly expressed 24-48 h after heat shock, and disappeared thereafter with time following a first-order kinetic with a 70 h half-life. This value was in the same range than the one described for the transduced C6 glioma cells. 18 Moreover, the halflife of the GFP alone under the heat inducible promoter was 48 h. 27 This difference could reflect better stability of the TK-GFP fusion protein in microglial cells. This value is interesting since it governs the delay between successive heat shocks to maintain a sufficient level of thymidine kinase expression during pharmacological treatment, both in vitro and in vivo.
In normal conditions, basal expression of the transgene was observed without exceeding 5% of the total population. Thus, a leak of transgene expression occurs. This phenomenon was also observed in the C6 glioma cell population, where 14% of the C6 cells expressed the fusion protein. 18 The HSP70 leaky expression was also detected with cerebellar microglia in primary cultures of both neurons and astrocytes, where 21% of the microglial population expressed the inducible HSP70 protein. 34 Thus, a basal level of transgene expression is not surprising. However, our cell model is applicable as GCV treatment provides a pharmacological control. Furthermore, the spatial and temporal control of gene expression will be obtained by precise microglial localization in and around the tumor, and in the future will be based on the use of internalized perovskite nanoparticles. Indeed, these nanoparticles containing manganese can induce a local hyperthermia, after applying radio frequency, by converting electromagnetic energy into heat. In addition, their Curie temperature, which is the maximal temperature reachable by these magnetic particles, can be set at 441C. 35 Thus, using their ability to internalize nanoparticles as well as their chemoattraction to the tumor, microglial cells could become local selfcontrolled heating vectors. Indeed, in the case of an infiltrating brain tumor, it will be then possible to reach the optimal temperature for gene therapy without having to heat the whole brain.
The estimated viability observed with trypan blue indicated that the GCV IC 50 measured in PHT cells after the heat shock was higher than the one measured in C6 glioma cells, 18 as well as in rat fibroblasts (0.036 mM).
29
Furthermore, the half effect was two times lower after 72 h than after 48 h of GCV incubation. This could be due to a higher amount of apoptotic bodies released by the dead cells, which increased with the time of incubation with the prodrug. Moreover, these viability results showed that the GCV effect could induce up to 90% of mortality after 72 h of incubation, although 24 h after the heat shock, only 46% of the population expressed the transgene and, 96 h after this treatment, only 6% still expressed the TK-GFP at a level that was 50% of the maximal level. This phenomenon reflects a bystander effect due to gap junctions 36 and phagocytosis of apoptotic molecules by non-transduced microglia. This is advantageous because a minimal number of transduced microglia could be sufficient to exert a general effect on the tumoral population. Indeed, Culver et al. 37 already demonstrated that, in tumoral cells transduced with TK under the constitutive promoter CMV, rat glioma regressed completely when only 5-10% of the population expressed the enzyme. This result was also confirmed when as few as 10% of CD34 stem cells constitutively expressing TK killed about 60% of the total cellular population. 38 Furthermore, after 72 h of GCV incubation, there was a two time decrease in TK-GFP expression, but 90% of the entire population died. This suggests that the fusion-protein concentration was still sufficient to maintain an apoptotic process that has been engaged before. Ninety-six hours after the heat shock, if cell location is correct, a second heat shock that will affect 5% of the residual TK-GFP expressing cells will allow a second efficient treatment.
Preceding results demonstrated that, 48 and 72 h after incubations with GCV, 80 and 90% of the microglia population died, respectively. These times correspond to 72 and 96 h after the heat shock, where only 10 and 6% of the population still express the TK-GFP. This percentage is in the range of the 5% of microglia cells expressing the TK-GFP due to the transgene escape. However, these 'TK-GFP' leaky cells have a lower sensitivity to GCV. Indeed, a decrease in the viability of these microglia cells that have not been submitted to the heat shock was only observed at GCV concentrations 30 times higher than the IC 50 (data not shown). These differences of sensitivity to GCV can be explained by the importance of the amount of apoptotic bodies that are in greater quantity when issued from at least 40% of the TK-GFP-expressing microglia cells following the heat shock and after 72 h of GCV incubation. This data is very important to determine the dose to inject in the animal in future studies with the aim to minimize the transgene escape consequences. Indeed, the GCV concentrations must be under 0.36 mM to induce a mortality only of cells that have been submitted to the heat shock. This will constitute an essential parameter of the pharmacological control.
The development of death-induced apoptosis was characterized by the increasing activity of the caspases 3 and 7, and the resulting increase in the fluorescent inhibitor binding. The level of apoptosis appeared related to GCV in terms of concentration and time. Moreover, the percentage of apoptotic cells was similar to the dead cell proportion estimated with trypan blue. Indeed, after 72 h of GCV incubation, cell mortality reached 90%, and caspase activities indicated that 90% of the microglial population had entered apoptosis. Consequently, the TK/GCV system seemed to induce microglial death via the apoptotic pathway (not apparently through mitochondrial functions, see below).
The accumulation of DiOC6 (3) showed that the population with a high fluorescence shifted to a less fluorescent population when the GCV concentration rose above 1 mM. Thus, this effect occurs at GCV concentrations much higher than the GCV IC 50 determined with trypan blue. This difference suggests that the decrease in the mitochondrial membrane potential occurred later in the cell death process, probably because the mitochondrial pathway is probably not involved in the GCVinduced apoptosis. Indeed, the TK-GFP system yields DNA replication that stops at the nuclear level. The hypothesis that mitochondria were involved very late is supported by the fact that there was no change in the scatter ratio (side over forward light scatter ratio) when the cells were incubated with GCV. Indeed, these parameters reflect cell granulometry and are strongly linked to mitochondrial density. 39 Non-invasive microglial imaging appears of interest in cerebral lesions, tumors and neurodegenerative diseases, since these cells are in an activated state and accumulate in the affected area. The phenomenon is particularly observable in tumors, where microglia and macrophages are highly present when chemoattractant factors are released by tumoral cells. 3 TRITC nanoparticles have been shown to be internalized by various cell types, including microglia and macrophages, especially in lysosomes, with a concentration in these compartments 50 times higher than the total contrast agent concentra-tion. 25, 40 This accumulation is sufficient to allow MR imaging. Furthermore, their viability and mitochondrial properties were not altered after incubation with nanoparticles. Another important point is that the internalization of the nanoparticles did not affect the transgene expression even after the heat shock. However, their increasing dehydrogenase activities during 48 h in the presence of silica beads could mean that the internalization and vesicle accumulation of contrast agent phenomena lead to transient metabolic readjustment in microglial cells. Even so, this internalization did not induce any transgene expression leak. In addition, the gadoliniumgrafted silica nanoparticles used in this study had a relaxivity rate much higher than the Gd-DOTA used during clinical exams (4.5 mM ) and other gadolinium-based contrast agents. For example, liposomes, which are 10 times larger, may internalize fewer gadolinium molecules since their relaxivity rate reaches only 35 mM À1 s. 22 Silica nanoparticles grafted to Gd-DTPA are therefore suitable for use in further in vivo studies. They also allow other chemical grafts for cell targeting using biological molecules like peptides 41 or immunoglobulins. This would offer good affinity for the immunitaryresident cell populations of the patient, which are already chemoattracted in the pathological area. Nevertheless, the variable permeability of the blood-brain barrier according to the grade of the tumor 42 can be consider as an obstacle that has to be solved to guarantee the efficiency of the strategy.
T 1 -weigthed MR images allowed the detection of nanoparticle-associated microglia cells due to a hypersignal, whereas C6 tumor cells were visualized with a higher contrast compared to muscles on T 2 -weigthed MR images. The in vivo experiments realized in this study demonstrated that PHT cells after incubations with the silica nanoparticles grafted to gadolinium were visualized during 1 week by MRI at 4.7 T in mice, allowing a noninvasive detection of these cells in the vicinity of a tumor. However, the decrease of the microglial signal-to-noise ratio during time could be due to the decrease of the nanoparticle retention ability by the PHT cells during time and/or to the cell motility of microglia inside and outside the tumor core that still grew. These phenomenons induce a dilution-like of the contrast agent microglial tanker and consequently an extinction of the NMR signal.
What is important to note is that imaging of PHT microglia by MRI showed that they kept the nanoparticles during 1 week. This timing is compatible with the migration time of microglia to brain, 6 the glioma image achievement and the GCV treatment. Moreover, in our model, microglia maintain their ability to stay surrounding the C6 tumor. This PHT local accumulation will be expected to increase the MR signal at the tumor border when implanted in the brain. Indeed, monocyte and macrophage concentrations have been already seen by MRI after USPIO uptake in the inflammation site of the blood-brain barrier. 20 These properties will allow the in vivo characterization of the microglial behavior, particularly the chemoattraction of labeled-PHT microglia to brain tumors after their blood injection. Furthermore, the nanoparticle retention time period is sufficient to visualize microglia cells that have been subjected to the induction of the transgene expression by hyperthermia since the half-life of the thymidine kinase is 70 h, and also to the GCV treatment as the cell mortality occurred 48 h after the administration of the drug. Moreover, the imaging delay allows a second heat shock after the first treatment steps to induce once more the gene therapy against glioma, without a re-injection of PHT microglia in the mice.
This in vivo phenomenon may need to determine the threshold of PHT cells detectable after incubation with gadolinium-grafted silica nanoparticles. To increase the sensitivity of this method, progresses on sequences or contrast agent structures have to be performed. The improvement of the Gd-DOTA grafting efficiency on the silice nanoparticles has already allowed the detection of 50 times less microglia cells at 4.7 T (data not shown). This result will soon enable us to increase the sensibility of this concept.
Conclusion
Taken altogether, these findings indicate that the microglial model could be suitable for transporting both a transgene for gene therapy and contrast agents for MRI localization. Furthermore, the hyperintensive signal obtained on MR images shows the interest of the novel gadolinium-grafted nanoparticles as contrast agents for cellular imaging. Before any clinical application, the cell vehicle lifespan in brain tumors, the clearance of the nanoparticles and the in vivo induction properties of TK-GFP gene expression will have to be investigated.
